Lyra Therapeutics, Inc. (LYRA)
0.53
+0.04
(+8.10%)
USD |
OTCM |
Apr 07, 16:00
Lyra Therapeutics EPS Diluted (Quarterly) : -3.916 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.03 |
| BioStem Technologies, Inc. | -0.67 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.951M |
| Revenue (Quarterly) | 0.007M |
| Total Expenses (Quarterly) | 6.958M |
| Enterprise Value | 15.07M |
| Gross Profit Margin (Quarterly) | -1.33K% |
| Profit Margin (Quarterly) | -99.30K% |
| Earnings Yield | -2.26K% |
| Normalized Earnings Yield | -2209.13 |